Osteoarthritis and Bone Disorders News

Patients with osteoarthritis who experience neck pain lasting longer than 1 year have a significant increased risk for all-cause mortality, according to data published in Arthritis Research & Therapy.

Patients with rheumatoid arthritis or osteoarthritis in rural areas are less likely to report in-person health care use, including physician visits and diagnostic tests, vs. those in urban areas, according to data.

Among older adults enrolled in an osteoarthritis cohort, those with foot symptoms such as pain and stiffness demonstrated a higher risk for death vs. those without foot symptoms, according to data published in Arthritis Care & Research.

Patients with intra-articular mineralization demonstrate a two-times higher likelihood of having frequent knee pain, as well as more intermittent or constant pain, according to data published in Arthritis & Rheumatology.

EP-104AR, an injectable form of fluticasone propionate designed slowly distribute through the knee joint and provide pain relief for up to 6 months, improved pain vs. a placebo over 12 weeks, according to the manufacturer.

SAN DIEGO — Mitigating infection risks while preventing flares is often a balancing act for rheumatologists managing patients undergoing hip or knee replacement, according to a presenter at the 2023 Congress of Clinical Rheumatology West.

SAN DIEGO — The ability to recognize common osteoarthritis risk factors will become increasingly critical in the coming decades, as recent data project the global prevalence of the disease will reach 1 billion by 2050, noted a speaker here.

Nearly 1 billion people will be burdened with osteoarthritis by 2050, according to data published in The Lancet Rheumatology.

Patients with hip or knee osteoarthritis who exercise fare better than patients who do not, with those demonstrating worse severity and function at baseline benefitting most acutely, according to data published in The Lancet Rheumatology.

SANTA FE, N.M. — In this video exclusive, Michael R. McClung, MD, discusses strategies for drug holidays and transitions between osteoporosis therapies.